Categories: News

Bybit Copy Trading TradFi Renews Loss Coverage Program with Enhanced Protection for All Traders

DUBAI, UAE, April 7, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, is bringing back its Bybit Copy Trading TradFi protection vouchers program, offering loss-safeguarded TradFi access for both new users and loyal traders. Starting now, eligible traders may claim protection vouchers of up to 100 USDT as they navigate macro uncertainties.

- Advertisement -

The recurring program supports Bybit Copy Trading TradFi users on their trading journey, enabling both newcomers and experienced traders to explore Copy Trading strategies with enhanced protection, all while leveraging the experience and expertise of Master Traders.

- Advertisement -

Benefits available to all qualifying members of the Bybit community include:

- Advertisement -

How it works

- Advertisement -
  1. Eligible traders may claim their Protection Voucher through the Copy Trading TradFi page on the Bybit app or web platform.
  2. Once claimed, participating users must follow a Master Trader and execute qualified TradFi copy trades.
  3. If the copy trade results in a loss, participants will receive compensation up to the corresponding voucher amount.

Seamlessly integrated with with Bybit’s Copy Trading Classic infrastructure, the Vouchers can function as trading margin for qualifying positions. Loss compensation becomes available when positions initiated by selected Master Traders close during the event period, with eligible rewards distributed within three days of qualification.

- Advertisement -

The Copy Trading TradFi protection vouchers complement Bybit’s broader ecosystem of trading tools and resources, supporting the platform’s mission to democratize access to sophisticated trading strategies. By offering tiered protection across experience levels, Bybit strives to help traders build confidence while mitigating downside risk during period of high volatility.

- Advertisement -

The vouchers are available periodically on a first-come, first-served basis. Terms and conditions are incorporated to ensure integrity. For details of participation rules and eligibility, users may visit:

- Advertisement -

#Bybit / #TheCryptoArk / #IMakeIt

- Advertisement -

About Bybit

- Advertisement -

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 80 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

- Advertisement -

For more details about Bybit, please visit Bybit Press
For media inquiries, please contact: media@bybit.com
For updates, please follow: Bybit’s Communities and Social Media

- Advertisement -

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

- Advertisement -

Photo – https://mma.prnewswire.com/media/2951063/image_977099_28872716.jpg
Logo – https://mma.prnewswire.com/media/2932256/Bybit_TNFP_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/bybit-copy-trading-tradfi-renews-loss-coverage-program-with-enhanced-protection-for-all-traders-302735565.html

- Advertisement -

Recent Posts

Deepak Group Goes Beyond Green with hands-On Mangrove Restoration

Deepak Group undertakes mangrove plantation drive on World Environment DaySustainable restoration along the Paniyadra coast,…

9 hours ago

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (ADA) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction,…

13 hours ago

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Presentations will feature clinical results for ribupatide, a GLP-1/GIP receptor dual agonist being developed as…

13 hours ago

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)…

13 hours ago

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

June 05, 2026 20:13 ET  | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up…

13 hours ago